Skip to main content
SpringerLink
Log in

Corticosteroids first-line therapy in the treatment of croup

  • Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Maschke M, Kastrup O, Diener H-C. CNS manifestations of cytomegalovirus infections: diagnosis and treatment. CNS Drugs 2002; 16 (5): 303–15

    Article  PubMed  CAS  Google Scholar 

  2. Emery VC. Cytomegalovirus and the aging population. Drugs Aging 2001; 18 (12): 927–33

    Article  PubMed  CAS  Google Scholar 

  3. Moretti S, Zikos P, Van Lint MT, et al. Forscarnet vs ganciclovir for cytomegalovirus (CMV) antigenemia after allogeneic hemopoietic stem cell transplantation (HSCT): a randomised study. Bone Marrow Transplant 1998; 22: 175–80

    Article  PubMed  CAS  Google Scholar 

  4. Serabe BM, Murray DJ, Dauser R, et al. Plasma and CSF pharmacokinetics of ganciclovir in nonhuman primates. Cancer Chemother Pharmacol 1999; 43: 415–8

    Article  PubMed  CAS  Google Scholar 

  5. Sjovall J, Bergdahl S, Movin G, et al. Pharmacokinetics of foscarnet and distribution to cerebrospinal fluid after intravenous infusion in patients with human immunodeficiency virus infection. Antimicrob Agents Chemother 1989; 33: 1023–31

    Article  PubMed  CAS  Google Scholar 

  6. Anduze-Faris BM, Fillet AM, Gozlan J, et al. Induction and maintenance therapy of cytomegalovirus central nervous system infection in HIV-infected patients. AIDS 2000; 14: 517–24

    Article  PubMed  CAS  Google Scholar 

  7. Cohen BA. Prognosis and response to therapy of cytomegalovirus encephalitis and meningomyelitis in AIDS. Neurology 1996; 46: 444–50

    Article  PubMed  CAS  Google Scholar 

  8. Whitley RJ, Jacobson MA, Friedberg DN, et al. Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society-USA. Arch Intern Med 1998; 158: 957–69

    Article  PubMed  CAS  Google Scholar 

  9. Cinque P, Cleator GM, Weber T, et al. Diagnosis and clinical management of neurological disorders caused by cytomegalovirus in AIDS patients. European Union Concerted Action on Virus Meningitis and Encephalitis. J Neuroviral 1998; 4: 120–32

    Article  CAS  Google Scholar 

  10. Emery VC, Hassan-Walker AF. Focus on new drugs in development against human cytomegalovirus. Drugs 2002; 62 (13): 1853–8

    Article  PubMed  CAS  Google Scholar 

  11. Stannard W, O’Callaghan C. Management of croup. Pediatr Drugs 2002; 4 (4): 231–40

    Google Scholar 

  12. Denny FW, Murphy TF, Clyde WA, et al. Croup: an 11-year study in a pediatric practice. Pediatrics 1983; 71 (6): 871–6

    PubMed  CAS  Google Scholar 

  13. Westley CR, Cotton EK, Brooks JG. Nebulized racemic epinephrine by IPPB for the treatment of croup: a double-blind study. Am J Dis Child 1978; 132: 484–7

    PubMed  CAS  Google Scholar 

  14. Yates RW, Doull IJM. A risk-benefit assessment of corticosteroids in the management of croup. Drug Saf 1997 Jan; 16 (1): 48–55

    Article  PubMed  CAS  Google Scholar 

  15. Dowell SF, Bresee JS. Severe varicella associated with steroid use. Pediatrics 1993; 92: 223–8

    PubMed  CAS  Google Scholar 

  16. Rittichier KK, Ledwith CA. Outpatient treatment of moderate croup with dexamethasone: intramuscular versus oral dosing. Pediatrics 2000; 106 (6): 1344–8

    Article  PubMed  CAS  Google Scholar 

  17. Geelhoed GC, Macdonald WBG. Oral dexamethasone in the treatment of croup: 0.15 mg/kg versus 0.3 mg/kg versus 0.6 mg/kg. Pediatr Pulmonol 1995; 20: 362–8

    Article  PubMed  CAS  Google Scholar 

  18. Geelhoed GC, Turner J, Macdonald WBG. Efficacy of a small single dose of oral dexamethasone for outpatient croup: a double blind placebo controlled clinical trial. BMJ 1996; 313: 140–2

    Article  PubMed  CAS  Google Scholar 

  19. Godden CW, Campbell MJ, Hussey M, et al. Double blind, placebo controlled trial of nebulised budesonide for croup. Arch Dis Child 1997; 76 (2): 155–7

    Article  PubMed  CAS  Google Scholar 

  20. Klassen TP, Feldman ME, Watters LK, et al. Nebulized budesonide for children with mild-to-moderate croup. N Engl J Med 1994; 331 (5): 285–9

    Article  PubMed  CAS  Google Scholar 

  21. Roberts GW, Master VV, Staugas RE, et al. Repeated dose inhaled budesonide versus placebo in the treatment of croup. J Paediatr Child Health 1999; 35: 170–4

    Article  PubMed  CAS  Google Scholar 

  22. Kelley PB, Simon JE. Racemic epinephrine use in croup and disposition. Am J Emerg Med 1992; 10: 181–3

    Article  PubMed  CAS  Google Scholar 

  23. Tibballs J, Shann FA, Landau LI. Placebo-controlled trial of prednisolone in children intubated for croup. Lancet 1992; 340: 745–8

    Article  PubMed  CAS  Google Scholar 

  24. Roorda RJ, Walhof CM. Effects of inhaled fluticasone proprionate administered with metered dose inhaler and spacer in mild to moderate croup: a negative preliminary report. Paediatr Pulmonol 1998; 25: 114–7

    Article  CAS  Google Scholar 

  25. Jothimurugan S, Zoaka H, Silverman M. Effectiveness of glucocorticoids in treating croup: children with croup should receive corticosteroids in primary care: results of audit [letter]. BMJ 1999; 319 (7224): 1577

    Google Scholar 

  26. Tillett AJ, Gould JDM. Effectiveness of glucocorticoids in treating croup: general practitioners must be ready to treat children [letter]. BMJ 1999; 319 (7724): 1577

    PubMed  CAS  Google Scholar 

  27. Klassen TP. Croup: a current perspective. Pediatr Clin North Am 1999; 46 (6): 1167–78

    Article  PubMed  CAS  Google Scholar 

  28. Waisman Y, Klein BL, Boenning DA, et al. Prospective randomized double-blind study comparing L-epinephrine and racemic aerosols in the treatment of laryngotracheitis (croup). Pediatrics 1992; 89 (2): 302–6

    PubMed  CAS  Google Scholar 

  29. Nutman J, Brooks LJ, Deakins KM, et al. Racemic versus L-epinephrine aerosol in the treatment of postextubation laryngeal edema: results from a prospective, randomized, double-blind study. Crit Care Med 1994; 22 (10): 1591–4

    PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Corticosteroids first-line therapy in the treatment of croup. Drugs Ther. Perspect 19, 15–17 (2003). https://doi.org/10.2165/00042310-200319040-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200319040-00005

Keywords

Search

Navigation